InflaRx (IFRX) Total Non-Current Liabilities (2016 - 2026)

InflaRx's (IFRX) quarterly Total Non-Current Liabilities came in at $712532.2 in Q1 2026, up 103.83% year-on-year from $349563.3 in Q1 2025, and down 9.7% quarter-over-quarter from $789046.9 in Q4 2025.

InflaRx (IFRX) Total Non-Current Liabilities (2016 - 2026) Analysis & Trends

InflaRx has disclosed Total Non-Current Liabilities across 11 years of filings, most recently posting $712532.2 for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $712532.2, up 103.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $712532.2 (up 103.83% YoY), and the FY2025 annual result was $789046.9, up 69.38% from the prior year.
  • Total Non-Current Liabilities came in at $712532.2 for Q1 2026 at InflaRx, down from $789046.9 in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.3 million in Q2 2022 to a low of $272525.0 in Q2 2025.
  • The 5-year median for Total Non-Current Liabilities is $842023.0 (2023), against an average of $811990.8.
  • Across the five-year window, Total Non-Current Liabilities jumped 446.31% in 2022 and slumped 60.34% in 2025, its largest moves.
  • InflaRx's Total Non-Current Liabilities stood at $1.0 million in 2022, then decreased by 19.42% to $842023.0 in 2023, then sank by 44.68% to $465846.7 in 2024, then soared by 69.38% to $789046.9 in 2025, then decreased by 9.7% to $712532.2 in 2026.
  • The last three Total Non-Current Liabilities figures came in at $712532.2 (Q1 2026), $789046.9 (Q4 2025), and $861618.2 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 42,980.09
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 11.03 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 644,700.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.26 Bn 94.26 Bn - 64.76 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 712,532.19

Historic Data

Download Data
DateValue
Mar 31, 2026 712,532.19
Dec 31, 2025 789,046.90
Sep 30, 2025 861,618.15
Jun 30, 2025 272,524.95
Mar 31, 2025 349,563.29
Dec 31, 2024 465,846.68
Sep 30, 2024 588,431.50
Jun 30, 2024 687,131.81
Mar 31, 2024 829,909.78
Dec 31, 2023 842,023.04
Sep 30, 2023 880,333.32
Jun 30, 2023 927,150.52
Mar 31, 2023 1.00 Mn
Dec 31, 2022 1.04 Mn
Sep 30, 2022 1.13 Mn
Jun 30, 2022 1.29 Mn
Mar 31, 2022 1.13 Mn
Dec 31, 2021 1.26 Mn
Sep 30, 2021 1.40 Mn
Jun 30, 2021 1.54 Mn